MHC-I presents viral antigens for CD8+ cytotoxic T lymphocyte (CTL) activation. Upon activation, these cells kill and eliminate virus-infected cells throughout the human body. Several viruses have ...

Thea van de Mortel teaches into the Griffith University Master of Infection Prevention and Control program. You’ve tested negative for COVID using a rapid antigen test (RAT), but are a close contact ...

The FDA, on Oct 12, expanded the eligibility of the granted emergency use authorization (EUA) to Omicron BA.4/BA.5-adapted bivalent vaccines developed by Pfizer PFE/BioNTech BNTX and Moderna MRNA. The ...

With our free press under threat and federal funding for public media gone, your support matters more than ever. Help keep the LAist newsroom strong, become a monthly member or increase your support ...

Throughout the pandemic, the virus that causes COVID-19 has been evolving fast, blindsiding the world with one variant after another. But the World Health Organization hasn't given a SARS-CoV-2 ...

Neil Mabbott does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...

Moncef Slaoui, the former head of the Trump administration's Operation Warp Speed, says he's "cautiously optimistic" about how well existing vaccines will hold up against omicron, the latest ...

NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization ...

Data support request for Emergency Use Authorization of a 30-µg booster dose of an Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine for individuals 12 years of age and older Companies have rapidly ...